Re: heard back from Sarah..
|
1
|
Resverlogix Corp.
|
Oct 04, 2021 12:39PM
|
Presentation
|
7
|
Resverlogix Corp.
|
Oct 04, 2021 05:03PM
|
Re: Presentation
|
4
|
Resverlogix Corp.
|
Oct 05, 2021 11:45AM
|
Re: Presentation
|
|
Resverlogix Corp.
|
Oct 05, 2021 07:20PM
|
Re: Presentation
|
4
|
Resverlogix Corp.
|
Oct 07, 2021 07:00PM
|
Re: AGM
|
|
Zenith Epigenetics
|
Oct 08, 2021 10:22AM
|
AGM Content
|
3
|
Zenith Epigenetics
|
Oct 08, 2021 10:44AM
|
Re: AGM Content
|
2
|
Zenith Epigenetics
|
Oct 14, 2021 11:20AM
|
Re: Optimistic
|
8
|
Resverlogix Corp.
|
Oct 16, 2021 12:33PM
|
Re: Optimistic
|
2
|
Resverlogix Corp.
|
Oct 18, 2021 12:37PM
|
Re: Optimistic
|
4
|
Resverlogix Corp.
|
Oct 18, 2021 06:54PM
|
Re: Optimistic
|
4
|
Resverlogix Corp.
|
Oct 19, 2021 10:37AM
|
Re: Potential funding for BETONMACE2 and Covid trial
|
5
|
Resverlogix Corp.
|
Oct 25, 2021 07:30PM
|
Re: Yet another potential indication: Reduction of drug-seeking behavior
|
4
|
Resverlogix Corp.
|
Oct 26, 2021 06:44PM
|
Re: AGM/rumour mill?'s
|
4
|
Zenith Epigenetics
|
Oct 27, 2021 04:11PM
|
AGM Fun
|
2
|
Zenith Epigenetics
|
Oct 28, 2021 11:34AM
|
Re: Enthusiasm? NOT!
|
6
|
Zenith Epigenetics
|
Oct 30, 2021 12:56PM
|
Re: Enthusiasm? NOT!
|
3
|
Zenith Epigenetics
|
Oct 30, 2021 06:00PM
|
Volume
|
1
|
Resverlogix Corp.
|
Nov 01, 2021 11:28AM
|
Re: Resverlogix In Active Discussions With The Kingdom of Morocco’s Ministry of Health For The Launch Of COVID-19 Clinical Studies With First-In-Class Dru
|
9
|
Resverlogix Corp.
|
Nov 02, 2021 12:19PM
|